Muğla Sıtkı Koçman Üniversitesi Eğitim ve Araştırma Hastanesi Yenidoğan İşitme Taraması Sonuçları

Abstract

Objective: The patients with congenital hearing loss can diagnosed and treated early with newborn hearing screening programs. The aim of this study was the evaluation of the newborn hearing screening outcomes at Mugla Education and Research Hospital and to compare the results with recent literature. Material and Methods: Infants who underwent hearing screening between January 2011 and December 2015 at Mugla Education and Research Hospital were included in the study. The newborns, with no risk factors, were screened using transient evoked otoacoustic emissions (TEOAE). The newborns who failed the first screening were tested again after one week with the TEOAE. The infants who failed the test twice and were under high risk were screened using Auditory Brainstem Response (ABR). If the infants failed to pass ABR screening they were referred to tertiary health center. results: A total of 6724 babies were tested in five years. There were 16 patients in 2011, 15 patients in 2012, 10 patients in 2013, 8 patients in 2014, and 14 patients in 2015 for a total of 63 (0.93%) patients referred to a tertiary center with a preliminary diagnosis of hearing loss. Seventeen patients (0.25%) were diagnosed with permanent hearing loss. Fifteen patients (0.22%) had bilateral and two (0.02%) had unilateral hearing loss. conclusion: Early diagnosis and rehabilitation of congenital hearing loss positively affects the language development and cognitive functions of the individuals. Therefore, it is very important to put effective hearing screening programs into practice. Testing with the combination of TEOAE and ABR reduce unnecessary referrals to the tertiary hearing center. ABR test is more useful than TEOAE in high-risk groups.